Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome
By P. Schwartz, S. Priori, M. Cerrone, C. Spazzolini, A. Odero, C. Napolitano, R. Bloise, Gaetano M. De Ferrari, C. Klersy, A. Moss and 8 more. Circulation, 2004
660 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/5abc7b99de097b520978e341a8bb9f0fb295f865
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “Left cervicothoracic sympathetic ganglionectomy is associated with reduction in the frequency of arrhythmogenic syncope in the congenital LQTS and may be useful as adjunctive therapy in high-risk patients with long QT who have recurrent syncope and/or aborted cardiac arrest despite combined ICD and ”
- HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. (2013, background): “This procedure is often effective in reducing the probability for arrhythmic events in high-risk patients, including those who are intolerant of or refractory to beta-blockers alone [47].”
- Long-QT syndrome: from genetics to management. (2012, methodology): “Left cardiac sympathetic denervation appears to confer significant protection from lifethreatening arrhythmias in the relatively small number of LQT3 patients who received this treatment (66).”